News (186)

Alnylam Issues 2023 Corporate Responsibility Report BU
Alnylam Pharmaceuticals : 2023 REPORT PU
Transcript : Alnylam Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024
Alnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activity BU
Transcript : Alnylam Pharmaceuticals, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 09:10 AM
Transcript : Alnylam Pharmaceuticals, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity BU
Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association BU
Transcript : Alnylam Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09:45 AM
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates BU
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 09:30 AM
Transcript : Alnylam Pharmaceuticals, Inc. Presents at 14th Annual Jefferies London Healthcare Conference 2023, Nov-14-2023 10:00 AM
Transcript : Alnylam Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 02, 2023
Alnylam Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Period Activity BU
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Alnylam Announces Receipt of Complete Response Letter from U.S. FDA for Supplemental New Drug Application for Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis BU
Transcript : Alnylam Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Alnylam Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Period Activity BU
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Roche enters partnership with Alnylam to co-develop and co-commercialise RNAi therapeutic zilebesiran to treat hypertension in patients with high cardiovascular risk GL
Alnylam Announces Partnership with Roche to Co-Develop and Co-Commercialize Zilebesiran, an Investigational RNAi Therapeutic for the Treatment of Hypertension in Patients with High Cardiovascular Risk BU
Transcript : Alnylam Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 04, 2023
Alnylam Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Period Activity BU
Alnylam Issues 2022 Corporate Responsibility Report BU
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy BU
Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy GL
Pacira BioSciences Announces Yvonne Greenstreet to Retire from Board of Directors GL
Pacira Biosciences Announces Yvonne Greenstreet to Retire from Board of Directors CI
Alnylam Announces Appointment of Peter Kellogg to Board of Directors BU
Transcript : Alnylam Pharmaceuticals, Inc., Q4 2022 Earnings Call, Feb 23, 2023
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Period Activity BU
Transcript : Alnylam Pharmaceuticals, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09:45 AM
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2022 Global Net Product Revenues and Provides Additional Updates BU
Alnylam Announces Updates to its Board of Directors BU
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
Alnylam Ranks #1 on Boston Globe’s Top Places to Work List for 2022 BU
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 09:30 AM
Transcript : Alnylam Pharmaceuticals, Inc. Presents at 13th Annual Jefferies London Healthcare Conference 2022, Nov-16-2022 02:05 PM
Transcript : Alnylam Pharmaceuticals, Inc., Q3 2022 Earnings Call, Oct 27, 2022
Alnylam Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Period Activity BU
Alnylam Announces New Management Appointments BU
Alnylam Pharmaceuticals, Inc. Announces Executive Appointments CI
Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
1234NextSee all

Insiders

Picture Yvonne Greenstreet
Yvonne Greenstreet

Yvonne L. Greenstreet founded Highgate LLC. Currently, Dr. Greenstreet is President & Chief Operating Officer of Alnylam Pharmaceuticals, Inc. Dr. Greenstreet is also on the board of Pacira Biosciences, Inc. and Member of The Association of the British Pharmaceutical Industry. Dr. Greenstreet previously occupied the position of Managing Director at Highgate LLC, Senior Vice President & Head-Medicines Development at Pfizer Inc. and Chief Strategy-R&D, Senior Vice President at GlaxoSmithKline Plc. Yvonne L. Greenstreet received an MBA from INSEAD and an undergraduate degree from the University of Leeds.


Picture Yvonne Hodge
Yvonne Hodge

Yvonne O.
Hodge
is currently the Chief Information Officer & Senior Vice President at Lockheed Martin Corp.
She obtained an undergraduate degree from Montclair State University.


Picture Yvonne McGill
Yvonne McGill

Yvonne McGill is an Independent Director at Applied Materials, Inc. She is also a Director at the Susan G.
Komen Foundation.
Previously, she served as the Chief Financial Officer & Vice President at Dell Technologies Japan, Inc., Dell Asia Pacific Sdn.
Bhd., and Dell Technologies, Inc. She also held the position of Chief Accounting Officer & VP-Corporate Finance at Dell, Inc. from 2012 to 2013.
Additionally, she worked as an Assistant Controller at ManTech International Corp.
Ms. McGill obtained her undergraduate degree from Virginia Polytechnic Institute & State University.


Picture Michelle M. Greenstreet
Michelle M. Greenstreet

Michelle M.
Greenstreet
formerly worked at Citibank NA (New York), as Senior Vice President & Director-Human Resource, United Parcel Service, Inc., as Principal, Texas Workforce Commission, as Principal, Caliber Home Loans, Inc., as Chief Human Resources Officer & Executive VP from 2012 to 2014, Vericrest Financial, Inc., as Chief Human Resources Officer, and Spirit Realty Capital, Inc., as Chief Administrative Officer & Executive VP.
Ms. Greenstreet received her undergraduate degree from Texas A&M University.


Picture Preba Greenstreet
Preba Greenstreet

Preba Greenstreet worked as a Director at Guinness Ghana Breweries Plc.


Picture Jim Greenstreet
Jim Greenstreet

Jim Greenstreet currently works at Sunland Fire Protection, Inc., as Design Manager.



Picture James John Pryn Greenstreet
James John Pryn Greenstreet

James John Pryn Greenstreet is the founder of Newmarket Capital Ltd.
which was founded in 2001 where he holds the title of Head-Corporate Finance.
He currently holds the position of Director at CityJet DAC and Electric Aviation Group Ltd.
Additionally, he is the Executive Vice President at Falko Regional Aircraft Ltd.
since 2011.
Mr. Greenstreet's former positions include being a Non-Executive Director at Powerhouse Energy Group Plc from 2021 to 2022, an Independent Non-Executive Director at Powerhouse Energy Group Plc from 2011 to 2021, and a Principal at BAE Systems Plc, IBM United Kingdom Ltd., XL Capital Assurance (UK) Ltd., and Arthur Andersen (UK).


Picture Michael Greenstreet
Michael Greenstreet

Michael Greenstreet currently works as a Director for Easter Seals New Jersey, Inc.










Picture Ian Greenstreet
Ian Greenstreet

Ian O.
Greenstreet
is the founder of Infinity Capital Partners Ltd.
He currently holds positions as an Independent Non-Executive Director at The Principality Building Society and at Simmons & Simmons LLP.
Previously, he held positions as an Independent Non-Executive Director at Lesaka Technologies, Inc., an Independent Director at Diamond Bank Plc, and as a Director & Head at Henderson Fund Management (Luxembourg) SA, among others.
He received his undergraduate degree from The University of Manchester.







Picture Yvonne D’Alpaos-Götz
Yvonne D’Alpaos-Götz

Yvonne D’Alpaos-Götz served as a Member-Supervisory Board at ALTANA AG in 2006 and also held the same position at ALTANA Pharma AG.





Picture Yvonne Tyrer
Yvonne Tyrer

Yvonne Tyrer currently works as a Director for The Communications & Information Technology Association.











Picture Yvonne E. Johnston
Yvonne E. Johnston

Yvonne E.
Johnston
is currently a Director at both the South African Tourism Board and the Valued Citizens Initiative.
Previously, she was a Non-Executive Director at African Sun Ltd.
from 2009 to 2011.


Picture Yvonne Muthien
Yvonne Muthien

Yvonne G.
Muthien
is currently the Independent Non-Executive Chairman at RFG Holdings Ltd.
and the Chairman at Thebe Resource Incubator.
She is also an Independent Non-Executive Director at Aspen Pharmacare Holdings Ltd., a Non-Executive Director at the South African Reserve Bank, a Director at Terracotta Mining & Resources Pty Ltd., Kwelokhozi Wilderness, and the Council of Sol Plaatje University.
Additionally, she serves as a Board of Director at The SA Sme Fund and the Independent Non-Executive Chairperson at Rhodes Food Group Holdings Ltd.
In her former positions, Dr. Muthien served as the Independent Non-Executive Chairman at South African Bankers Services Co. Ltd.
from 2014 to 2018.
She was also the Chairman of the Presidents Advisory Council On National Orders from 1998 to 2014.
Furthermore, she held the role of Executive Director at Sanlam Ltd.
from 2011 to 2012.
Dr. Muthien has also held various non-executive director positions at Transnet SOC Ltd., Sanlam Life Insurance Ltd., Thebe Investment Corp., Sentech Ltd., Aurecon South Africa (Pty) Ltd., Santam Ltd., Sanlam Investment Management (Pty) Ltd., MTN Nigeria Communications Plc, and Sanlam Investments Corp.
She was the Group Executive Corporate Affairs at MTN Group Ltd.
and the Vice President-Public Affairs at Coca-Cola Africa (Pty) Ltd.Dr. Muthien obtained a doctorate degree from the University of Oxford in 1989.
She also holds a graduate degree from Northwestern University (1980) and an undergraduate degree from the University of the Western Cape (1978).


Picture Yvonne Campos
Yvonne Campos

Yvonne Campos is the President and founder of Next Act Fund (Management), which was founded in 2016.
She is currently the Director at Govenda, Inc. since 2014, Director at Highmark, Inc., and Director at Goodwill of Southwestern Pennsylvania since 2015.
Ms. Campos completed her undergraduate degree at the University of Utah in 1973.



Picture Yvonne Gooch
Yvonne Gooch

Yvonne Gooch is a Senior Vice President-Risk Management who currently works at The Farmers National Bank of Danville.
She previously held the same position at Boyle Bancorp, Inc.










Picture Yvonne Maher
Yvonne Maher

Yvonne Maher has a current job as Vice President-Development & Donor Services at The Pittsburgh Foundation.


Picture Yvonne Boël
Yvonne Boël

Yvonne Boël is currently the Chairman of Fonds Ms. Boël.
Previously, she worked as an Independent Director at Solvac SA from 2006 to 2017.




Picture Yvonne Fertnig
Yvonne Fertnig

Yvonne Fertnig is currently working as an Investor Relations Contact at M J Gleeson Group Ltd.
Previously, she held the same position at MJ Gleeson Plc.






Picture Yvonne Russo
Yvonne Russo

Yvonne Russo is currently the Vice Chairman at Exide Technologies SA since 2010.
She is also a Director at Exide Technologies BV, Managing Director at Exide Holding Europe SAS, Director at Exide Global Holding Netherlands CV, and Director at GNB Industrial Power (UK) Ltd.
She previously served as the Chairman at Exide Technologies SAS.














Picture Yvonne Zappulla
Yvonne Zappulla

Yvonne Zappulla is currently a Managing Director at Dutchess Capital Management LLC and Grannus Financial Advisors, Inc. She was previously a Principal at Middlebury Securities LLC.
She received an undergraduate degree from Dickinson College and an MBA from A.B.
Freeman School of Business.



Picture Yvonne Demandt
Yvonne Demandt

Yvonne Demandt has a current job as the Head of Sales & Marketing at ProfCore Business Services BV.



Picture Yvonne Wanders
Yvonne Wanders

Ms. Yvonne Wanders, partner, assumed the role of Head of Sales and Marketing in Aravis on 1st January 2011.
She has 17 years sales and marketing experience in the financial industry.
Prior to joining Aravis, she was sales manager (Prokurist) at Bank Syz & Co SA Oyster Funds responsible for the german market and later also for parts of the Swiss German speaking regiion.
Before joining Bank Syz & Co SA in Geneva, she was working together with a group of financial advisors in Düsseldorf and built up an office in Montreux(CH).
Ms. Wanders is a graduate of the "Chambre Syndicale de la Couture Parisienne" and completed her studies in business administration at VWA Düsseldorf and economic science at Fernuni Hagen.





Picture Yvonne Schers
Yvonne Schers

Yvonne Schers currently works as a Vice President-Public Affairs & General Counsel at UPC Nederland BV.








Picture Yvonne Voon
Yvonne Voon

Yvonne Voon is currently a Partner at Fifth Wall Ventures Management LLC.
Previously, she worked as a Research Analyst at OSK Research Sdn.
Bhd., Credit Suisse Securities (Malaysia) Sdn.
Bhd., and Credit Suisse (Singapore) Ltd.
She also served as the Head of Southeast Asia Real Estate at Credit Suisse Singapore Ltd.
(Private Banking) from 2018 to 2021.
Ms. Voon obtained her undergraduate degree from the University of Melbourne in 2005.





Picture Yvonne Thabiso Moerane
Yvonne Thabiso Moerane

Yvonne Thabiso Moerane served as an Independent Non-Executive Director at Pinnacle Point Group Ltd., SecureData Holdings Ltd., and PSV Holdings Ltd.
She was also the Managing Director at Khulumanjalo Group and Black Information Technology Empowerment Co. Ltd.
Moerane holds a graduate degree from Instituto de Empresa SL and an MBA from The Fuqua School of Business.









No results for this search

  1. Stock Market
  2. Advanced search
  3. Yvonne Greenstreet
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW